This document discusses methodological considerations for analyzing biological data from social surveys. It compares clinic and home collection of biomarker samples, noting ideal clinic conditions versus potential delays in home collections. Quality control processes are important, including measures of within-lab and between-lab variability. Specific biomarkers like C-Reactive Protein are discussed, including normal ranges and influencing factors like medication, gender, and sample transformations.